Corcept Therapeutics Inc CORT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/26/21 EST
21.49UNCH (UNCH)
Close
21.49quote price arrow down-0.97 (-4.32%)
Volume
468,987
52 week range
17.57 - 31.18
Loading...
  • Open22.22
  • Day High22.60
  • Day Low21.41
  • Prev Close22.46
  • 52 Week High31.18
  • 52 Week High Date02/09/21
  • 52 Week Low17.57
  • 52 Week Low Date10/27/21

Key Stats

  • Market Cap2.491B
  • Shares Out115.93M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-17.85

KEY STATS

  • Open22.22
  • Day High22.60
  • Day Low21.41
  • Prev Close22.46
  • 52 Week High31.18
  • 52 Week High Date02/09/21
  • 52 Week Low17.57
  • 52 Week Low Date10/27/21
  • Market Cap2.491B
  • Shares Out115.93M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-17.85

RATIOS/PROFITABILITY

  • EPS (TTM)0.84
  • P/E (TTM)25.62
  • Fwd P/E (NTM)26.76
  • EBITDA (TTM)107.487M
  • ROE (TTM)19.99%
  • Revenue (TTM)343.09M
  • Gross Margin (TTM)98.51%
  • Net Margin (TTM)28.45%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/07/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corcept Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Corcept Therapeutics Incorporated is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the steroid hormone cortisol. The Company has marketed the cortisol modulator Korlym in the United States for the treatment of patients with a form of hypercortisolism known as endogenous Cushing’s syndrome. Cortisol activity can be modulated effectively by a drug that...
James Wilson
Non-Executive Chairman
Joseph Belanoff M.D.
President
Atabak Mokari
Chief Financial Officer
Joseph Lyon
Chief Accounting Officer
Address
149 Commonwealth Dr
Menlo Park, CA
94025-1133
United States

Top Peers

SYMBOLLASTCHG%CHG
HRMY
Harmony Biosciences Holdings Inc
37.55-0.84-2.19%
PCRX
Pacira Biosciences Inc
51.63-2.62-4.83%
IRWD
Ironwood Pharmaceuticals Inc
11.16-0.42-3.63%
HSKA
Heska Corp
170.95-4.26-2.43%
TVTX
Travere Therapeutics Inc
29.03-1.27-4.19%